We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKY icon
2351
Rocky Brands
RCKY
$353M
$114K ﹤0.01%
2,047
CLPT icon
2352
ClearPoint Neuro
CLPT
$470M
$113K ﹤0.01%
+5,911
New +$114K
APLT
2353
DELISTED
Applied Therapeutics
APLT
$112K ﹤0.01%
5,405
+4,480
+484% +$84.8K
WSBF icon
2354
Waterstone Financial
WSBF
$385M
$112K ﹤0.01%
5,712
-2,744
-32% -$55.2K
ORMP icon
2355
Oramed Pharmaceuticals
ORMP
$182M
$112K ﹤0.01%
+8,386
New +$95.9K
ESI icon
2356
Element Solutions
ESI
$9.51B
$112K ﹤0.01%
4,785
+391
+9% +$8.6K
RYAM icon
2357
Rayonier Advanced Materials
RYAM
$570M
$112K ﹤0.01%
16,720
+5,402
+48% +$44K
ATOM icon
2358
Atomera
ATOM
$212M
$112K ﹤0.01%
5,210
RNAC icon
2359
Cartesian Therapeutics
RNAC
$264M
$111K ﹤0.01%
+888
New +$106K
CCNE icon
2360
CNB Financial Corp
CCNE
$1.04B
$111K ﹤0.01%
4,866
MSGN
2361
DELISTED
MSG Networks Inc.
MSGN
$111K ﹤0.01%
7,594
+704
+10% +$10.9K
FLXN
2362
DELISTED
Flexion Therapeutics, Inc.
FLXN
$110K ﹤0.01%
13,414
+2,025
+18% +$17.2K
LCTX icon
2363
Lineage Cell Therapeutics
LCTX
$268M
$110K ﹤0.01%
+38,709
New +$100K
FRST icon
2364
Primis Financial Corp
FRST
$413M
$110K ﹤0.01%
+7,214
New +$108K
GEF.B icon
2365
Greif Class B
GEF.B
$4.22B
$110K ﹤0.01%
1,862
OMF icon
2366
OneMain Financial
OMF
$7.51B
$110K ﹤0.01%
1,831
+353
+24% +$20K
KODK icon
2367
Kodak
KODK
$978M
$109K ﹤0.01%
+13,136
New +$103K
UHAL icon
2368
U-Haul Holding Co
UHAL
$14.4B
$109K ﹤0.01%
1,850
+40
+2% +$2.35K
CNTY icon
2369
Century Casinos
CNTY
$35.2M
$109K ﹤0.01%
+8,112
New +$106K
ROCC
2370
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$109K ﹤0.01%
+4,605
New +$84K
STGW icon
2371
Stagwell
STGW
$2.28B
$109K ﹤0.01%
+18,553
New +$86.7K
NOTV
2372
DELISTED
Inotiv
NOTV
$108K ﹤0.01%
+4,061
New +$102K
TLYS icon
2373
Tilly's
TLYS
$122M
$108K ﹤0.01%
+6,760
New +$91.1K
CURO
2374
DELISTED
CURO Group Holdings Corp.
CURO
$108K ﹤0.01%
+6,332
New +$98.3K
LMND icon
2375
Lemonade
LMND
$4.1B
$108K ﹤0.01%
983
+309
+46% +$28.1K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.